Author:
Chatterji Biswa Prasun,Banerjee Mithu,Singh Parminder,Panda Dulal
Subject
Pharmacology,Biochemistry
Reference55 articles.
1. Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals;Young;Cancer Res,1988
2. Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580);Conley;Cancer Res,1989
3. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion;Egorin;Cancer Res,1987
4. Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent;Andreeff;Blood,1992
5. Hexamethylene bisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4 (+) T cells;Choudhary;J Infect Dis,2008
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献